Haloperidol and prolactin concentrations in asians and caucasians

Journal of Clinical Psychopharmacology

Volumn 8, Issue 3, 1988, Pages 195-201

  Lin, Keh Ming ^a   Poland, Russell E ^a   Lau, John K ^a   Rubin, Robert T ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; HALOPERIDOL; PROLACTIN;

ADULT; BLOOD LEVEL; ETHNIC OR RACIAL ASPECTS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RACE;

ADULT; AGE FACTORS; ASIA; CAUCASOID RACE; HALOPERIDOL; HUMAN; MALE; MONGOLOID RACE; PROLACTIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023935333     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-198806000-00008     Document Type: Article

References (24)

1. Lin KM, Poland R, Lesser IM. Ethnicity and psychopharmacology. Culture Med Psychiatry 1986;10:151-65.
2. Murphy HBM. Ethnic variations in drug responses. Transcultural Psychiatr Res Rev 1969;6:6-23.
3. Okuma T. Differential sensitivity to the effects of psychotropic drugs: psychotics vs normals; Asians vs Western populations. Folia Psychiatr Neurol Jpn 1981;35:79-81.
4. Yamamoto J, Fung D, Lo S, et al. Psychopharmacology for Asian Americans and Pacific Islanders. Psychopharmacol Bull 1979; 15:29-31.
5. Lin KM, Finder EJ. Neuroleptic dosage in Asians. Am J Psychiatry 1983;140:490-1.
6. Sramek JJ, Sayles MA, Simpson GM. Neuroleptic dosage for Asians: a failure to replicate. Am J Psychiatry 1986;143:535-6.
7. Binder RL, Levy R. Extrapyramidal reactions in Asians. Am J Psychiatry 1981;138:1243-4.
8. Potkin SG, Shen Y, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiatry Res 1984;12:167-72.
9. Haase HJ, Janssen PAJ. The action of neuroleptic drugs. Amsterdam: North-Holland Publishing, 1965.
10. Guy W. ECDEU assessment manual. Rockville, MD: US Depart-ment of Health, Education and Welfare, 1976.
11. Rubin RT, Forsman A, Heykants J, et al. Serum haloperidol determinations in psychiatric patients: comparison of methods and correlation with serum prolactin. Arch Gen Psychiatry 1980;37: 1069-74.
12. Rubin RT, Poland RE, O’Connor D, et al. Selective neuroendocrine effects of low-dose haloperidol in normal adult men. Psy-chopharmacology 1976;47:135-40.
13. Rubin RT, Hays SE. The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psycho-neuroendocrinology 1980;5:121-37.
14. Poland RE, Rubin RT. Radioimmunoassay of haloperidol in human serum: correlation of serum haloperidol with serum prolactin. Life Sci 1981;29:1837-45.
15. Dixon WJ. BMDP Statistical Software. Berkeley: University of California Press, 1983.
16. Rubin RT. Prolactin and schizophrenia. In: Meltzer HY, Bunney WE, Coyle JT, et al, eds. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:803-8.
17. Langer G, Sachar EJ, Halpern FS, et al. The prolactin response to neuroleptic drugs. A test of dopaminergic blockage: neuroendocrine studies in normal men. J Clin Endocrinol Metab 1977;45:996-1002.
18. Hays SE, Rubin RT. Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men. Psychopharmacology 1979;61:17-24.
19. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Nat Cancer Inst 1968;40:43-68.
20. Shanmugaratnam K, Tye CY. Liver cancer differentials in immigrant and local-born Chinese in Singapore. J Chronic Dis 1970; 23:443-8.
21. Luscombe DK. Factors influencing plasma drug concentrations. J Int Med Res 1977;5 (suppl 1):82-97.
22. Rawlins MD. Variability in response to drugs. Br Med J 1974; 4:91-4.
23. Forsman A, Ohman R. Applied pharmacokinetics of haloperidol in man. Curr Ther Res 1977;21:396-411.
24. Shvartsburd A, Dekirmejian H, Smith RC. Blood levels of haloperidol in schizophrenic patients. J Clin Psychopharmacol 1983;3:7-12.